体外式膜酸素供給装置の市場：モダリティ、年齢、コンポーネント、用途、エンドユーザー別-2025-2030年の世界予測

体外式膜酸素供給装置市場の2023年の市場規模は7億9,486万米ドルで、2024年には8億3,214万米ドルに達すると予測され、CAGR 4.55％で成長し、2030年には10億8,563万米ドルに達すると予測されています。

体外式膜酸素療法（ECMO）装置は、心臓や肺が自力では十分に機能しない患者に高度な呼吸・心臓サポートを提供する重要な生命維持装置です。これらの機械は、ヘルスケア、特に重症心不全や肺不全の患者を対象としたクリティカルケアにおいて重要な役割を果たしています。ECMOの主な使用事例としては、心臓手術からの回復期の患者への使用、呼吸困難の重症例への対応、呼吸困難の新生児への補助などがあります。ECMO装置の必要性は、患者を回復や他の高度な治療への橋渡しをする能力によって強調されます。最終用途の範囲は主に病院、呼吸器・心臓専門医療センター、高度新生児医療ユニットであり、タイムリーな介入が救命につながります。ECMO市場に影響を与える主な成長要因には、機械の効率と安全性を向上させる技術的進歩のほか、ライフスタイルの変化や高齢化による呼吸器疾患や心臓疾患の有病率の増加があります。ECMOの設定を最適化し、患者のモニタリングを強化する人工知能の統合や、ヘルスケア・インフラが成長する新興市場での拡大が、最新の潜在的ビジネスチャンスです。しかし、高額なコスト、専門的なトレーニングの必要性、出血や感染など使用時に生じる潜在的な合併症などの課題が、より広範な採用を制限しています。技術革新と事業の成長に拍車をかけるためには、費用対効果の高いECMOソリューションの開発、訓練された人材を拡大するための使い勝手の向上、未開拓地域のターゲット化などに重点を置くべきです。研究努力は、副作用を最小限に抑える素材や、使用の複雑さを軽減するシステムに集中できると思われます。同市場は、技術的、規制的、訓練的要求による高い参入障壁を特徴としているが、革新的なソリューションと戦略的パートナーシップを通じてこれらの課題をうまく軽減する企業にとっては、有利な成長をもたらします。

市場力学：急速に進化する体外式膜酸素供給装置市場の主要市場インサイトを公開

体外式膜酸素供給装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患と呼吸器疾患の流行
  • 新生児医療へのECMOの採用とECMOセンターの拡大
• 市場抑制要因
  • ECMO装置のリコール
• 市場機会
  • ECMO装置の継続的進歩
  • ECMO装置に対する世界の償還シナリオの改善
• 市場の課題
  • ECMOの操作と保守に伴う潜在的な複雑性

ポーターの5つの力：体外式膜酸素供給装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：体外式膜酸素供給装置市場における外部からの影響の把握

外部マクロ環境要因は、体外式膜酸素供給装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析体外式膜酸素供給装置市場における競合情勢の把握

体外式膜酸素供給装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス体外式膜酸素供給装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、体外式膜酸素供給装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患および呼吸器疾患の有病率
    • 新生児ケアにおけるECMOの導入とECMOセンターの拡大
  • 抑制要因
    • ECMO装置の有害リコール
  • 機会
    • ECMO装置の継続的な進歩
    • 世界中でECMO機器の償還シナリオを改善
  • 課題
    • ECMOの操作とメンテナンスに伴う潜在的な複雑さ
• 市場セグメンテーション分析
  • 方法：心臓と呼吸の両方のサポートを提供する静脈動脈ECMOの利用が増加
  • 年齢：呼吸器疾患および心臓疾患により成人におけるECMO装置の必要性が増加
  • コンポーネント：ECMO装置用の耐久性と生体適合性を備えた酸素供給装置に対するニーズの高まり
  • 応用：体外心肺蘇生法（ECPR）は、重要な臓器への酸素化血流を迅速に回復させるため、その使用が急増しています。
  • エンドユーザー：病院の集中治療室専用機器に対応する高度なECMO装置の開発
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 体外式膜酸素供給装置の市場：モダリティ別

• 動静脈ECMO
• 静脈動脈ECMO
• 静脈ECMO

第7章 体外式膜酸素供給装置の市場年齢別

• 成人用
• 新生児
• 小児科

第8章 体外式膜酸素供給装置の市場：コンポーネント別

• 抗凝固システム
• ブレンダー
• カニューレ
• 熱交換器
• 監視システム
• 酸素発生器
• ポンプ

第9章 体外式膜酸素供給装置の市場：用途別

• 心臓への応用
• 体外心肺蘇生
• 呼吸器系への応用

第10章 体外式膜酸素供給装置の市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第11章 南北アメリカの体外式膜酸素供給装置の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の体外式膜酸素供給装置の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの体外式膜酸素供給装置の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ニューサウスウェールズ州政府（NSW）によるモバイル心臓治療に関する新たな革新的な臨床試験
  • インスピラ・テクノロジーズ、世界最大の体外生命維持カンファレンスで医療機器のINSPIRA ARTシリーズを発表
  • AIIMS-RがECMO治療を開始
  • MGMヘルスケア、小児向け先進的ECMOケア施設を開設
  • アボットの生命維持システムがFDAの新たな認可を取得し、医師がより多くの重篤な患者を治療できるよう支援
  • 国内初のECMO装置が重要な役割を果たす
  • 中国、重症COVID-19患者向けに自社開発のECMO装置を販売承認

企業一覧

• Abbott Laboratories
• Abiomed, Inc.
• Baxter International Inc.
• Braile Biomedica
• Chalice Medical Ltd.
• CytoSorbents Corporation
• Dragerwerk AG & Co. KGaA
• Eurosets S.R.L.
• Getinge AB
• Guangdong Pigeon Medical Apparatus Co.,Ltd.
• Hengko Technology Co., Ltd.
• Inspira Technologies OXY B.H.N. Ltd.
• LivaNova PLC
• MC3 Cardiopulmonary
• Medtronic PLC
• MicroPort Scientific Corporation
• Nipro Corporation
• Origen Biomedical, Inc.
• Owgels Group
• Senko Medical Instrument Mfg. Co., Ltd.
• Shenzhen Mindray Biomedical Electronics Co. Ltd.
• Technimount System
• Terumo Corporation
• XENIOS AG by Fresenius Medical Care AG & Co. KGaA
• ZOLL Medical Corporation by Asahi Kasei Corporation

LIST OF FIGURES

• FIGURE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET RESEARCH PROCESS
• FIGURE 2. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET DYNAMICS
• TABLE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ARTERIOVENOUS ECMO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY NEONATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ANTICOAGULATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY BLENDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULAE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC APPLICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY APPLICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 48. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 50. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 75. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 76. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 80. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 81. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 82. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 166. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 167. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 168. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. POLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 186. POLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 187. POLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 188. POLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. POLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. QATAR EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 191. QATAR EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 192. QATAR EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 193. QATAR EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. QATAR EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 241. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2023

The Extracorporeal Membrane Oxygenation Machine Market was valued at USD 794.86 million in 2023, expected to reach USD 832.14 million in 2024, and is projected to grow at a CAGR of 4.55%, to USD 1,085.63 million by 2030.

Extracorporeal Membrane Oxygenation (ECMO) machines serve as critical life-support systems that provide advanced respiratory and cardiac support to patients whose heart and lungs are unable to function sufficiently on their own. These machines play a vital role in healthcare, particularly in critical care settings for patients with severe heart or lung failure. ECMO's primary applications include use in patients recovering from cardiac surgery, handling severe cases of respiratory distress, and assisting neonates with respiratory challenges. The necessity of ECMO machines is underscored by their ability to bridge patients to recovery or other forms of advanced therapy. The end-use scope predominantly covers hospitals, specialized respiratory and cardiac care centers, and advanced neonatal care units, where timely intervention can be life-saving. Key growth factors impacting the ECMO market include technological advancements that improve machine efficiency and safety, as well as the increasing prevalence of respiratory and cardiac conditions due to lifestyle changes and an aging population. The latest potential opportunities lie in the integration of artificial intelligence to optimize ECMO settings and enhance patient monitoring, along with expansion in emerging markets with growing healthcare infrastructure. However, challenges such as high costs, the need for specialized training, and potential complications arising from use, including bleeding and infection, limit broader adoption. To spur innovation and business growth, focus areas should include developing cost-effective ECMO solutions, enhancing user-friendliness to expand trained personnel, and targeting untapped regions. Research efforts could concentrate on materials minimizing adverse effects and systems that reduce the complexity of use. The market is characterized by high entry barriers due to technological, regulatory, and training demands, yet it presents lucrative growth for firms that successfully mitigate these challenges through innovative solutions and strategic partnerships.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Extracorporeal Membrane Oxygenation Machine Market

The Extracorporeal Membrane Oxygenation Machine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of cardiovascular and respiratory diseases
  • Adoption of ECMO for neonatal care and expansion of ECMO centers
• Market Restraints
  • Adverse recalls of ECMO machines
• Market Opportunities
  • Ongoing advancements in ECMO machines
  • Improving reimbursement scenario for ECMO machines worldwide
• Market Challenges
  • Potential complexity associated with the operation and maintenance of ECMO

Porter's Five Forces: A Strategic Tool for Navigating the Extracorporeal Membrane Oxygenation Machine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Extracorporeal Membrane Oxygenation Machine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Extracorporeal Membrane Oxygenation Machine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Extracorporeal Membrane Oxygenation Machine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Extracorporeal Membrane Oxygenation Machine Market

A detailed market share analysis in the Extracorporeal Membrane Oxygenation Machine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Extracorporeal Membrane Oxygenation Machine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Extracorporeal Membrane Oxygenation Machine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Extracorporeal Membrane Oxygenation Machine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Inc., Baxter International Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corporation, Dragerwerk AG & Co. KGaA, Eurosets S.R.L., Getinge AB, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hengko Technology Co., Ltd., Inspira Technologies OXY B.H.N. Ltd., LivaNova PLC, MC3 Cardiopulmonary, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shenzhen Mindray Biomedical Electronics Co. Ltd., Technimount System, Terumo Corporation, XENIOS AG by Fresenius Medical Care AG & Co. KGaA, and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Extracorporeal Membrane Oxygenation Machine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Modality, market is studied across Arteriovenous ECMO, Venoarterial ECMO, and Venovenous ECMO.
• Based on Age, market is studied across Adult, Neonate, and Pediatric.
• Based on Component, market is studied across Anticoagulation Systems, Blender, Cannulae, Heat Exchanger, Monitoring Systems, Oxygenator, and Pump.
• Based on Application, market is studied across Cardiac Application, Extracorporeal Cardiopulmonary Resuscitation, and Respiratory Application.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of cardiovascular and respiratory diseases
    • 5.1.1.2. Adoption of ECMO for neonatal care and expansion of ECMO centers
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse recalls of ECMO machines
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in ECMO machines
    • 5.1.3.2. Improving reimbursement scenario for ECMO machines worldwide
  • 5.1.4. Challenges
    • 5.1.4.1. Potential complexity associated with the operation and maintenance of ECMO
• 5.2. Market Segmentation Analysis
  • 5.2.1. Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support
  • 5.2.2. Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders
  • 5.2.3. Component: Increasing need for durable and biocompatible oxygenators for ECMO machines
  • 5.2.4. Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs
  • 5.2.5. End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Extracorporeal Membrane Oxygenation Machine Market, by Modality

• 6.1. Introduction
• 6.2. Arteriovenous ECMO
• 6.3. Venoarterial ECMO
• 6.4. Venovenous ECMO

7. Extracorporeal Membrane Oxygenation Machine Market, by Age

• 7.1. Introduction
• 7.2. Adult
• 7.3. Neonate
• 7.4. Pediatric

8. Extracorporeal Membrane Oxygenation Machine Market, by Component

• 8.1. Introduction
• 8.2. Anticoagulation Systems
• 8.3. Blender
• 8.4. Cannulae
• 8.5. Heat Exchanger
• 8.6. Monitoring Systems
• 8.7. Oxygenator
• 8.8. Pump

9. Extracorporeal Membrane Oxygenation Machine Market, by Application

• 9.1. Introduction
• 9.2. Cardiac Application
• 9.3. Extracorporeal Cardiopulmonary Resuscitation
• 9.4. Respiratory Application

10. Extracorporeal Membrane Oxygenation Machine Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Specialty Clinics

11. Americas Extracorporeal Membrane Oxygenation Machine Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. The Government of New South Wales (NSW)'s New Innovative Clinical Trial with Mobile Cardiac Treatment
  • 14.3.2. Inspira Technologies Unveils the INSPIRA ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
  • 14.3.3. AIIMS-R Starts ECMO Treatment
  • 14.3.4. MGM Healthcare Inaugurates Advanced ECMO Care Facility for Children
  • 14.3.5. Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
  • 14.3.6. First Domestic ECMO Machine to Play Vital Role
  • 14.3.7. China Grants Market Approval to Self-Developed ECMO Device for Severe COVID-19 Cases

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abiomed, Inc.
• 3. Baxter International Inc.
• 4. Braile Biomedica
• 5. Chalice Medical Ltd.
• 6. CytoSorbents Corporation
• 7. Dragerwerk AG & Co. KGaA
• 8. Eurosets S.R.L.
• 9. Getinge AB
• 10. Guangdong Pigeon Medical Apparatus Co.,Ltd.
• 11. Hengko Technology Co., Ltd.
• 12. Inspira Technologies OXY B.H.N. Ltd.
• 13. LivaNova PLC
• 14. MC3 Cardiopulmonary
• 15. Medtronic PLC
• 16. MicroPort Scientific Corporation
• 17. Nipro Corporation
• 18. Origen Biomedical, Inc.
• 19. Owgels Group
• 20. Senko Medical Instrument Mfg. Co., Ltd.
• 21. Shenzhen Mindray Biomedical Electronics Co. Ltd.
• 22. Technimount System
• 23. Terumo Corporation
• 24. XENIOS AG by Fresenius Medical Care AG & Co. KGaA
• 25. ZOLL Medical Corporation by Asahi Kasei Corporation